Greetings and welcome to the second quarter of 2025 IDEXX Corporation Urgence Conference Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance, please press star zero on your telephone keypad. Please note this conference call is being recorded. It is now my pleasure to introduce your host, Jim Giannacoris, Vice President, Investing Relations. Thank you. You may begin. Thank you. Good morning, everyone, and welcome to IDEX's second quarter 2025 earnings conference call. We released our second quarter financial results earlier this morning, and you can find both our press release and earnings call slide presentation in the investor relations section of our website, IDEXcorp.com. On the call with me today are Eric Ashleman, President and Chief Executive Officer of IDEX, and Akhil Mahendra, our Interim Chief Financial Officer and Vice President of Corporate Development. Today's call will begin with Eric providing highlights of our second quarter results and a discussion of our current business outlook and strategies. And Akhil will discuss additional financial details and our updated outlook for 2025. Following our prepared remarks, we will open up the line for questions. But before we begin, please refer to slide two of our presentation, where we note that comments today will include forward-looking statements based on current expectations. Actual results could differ materially from these statements due to a number of risks and uncertainties, which are discussed in our press release and SEC filings. As IDEXX provides non-GAAP financial information, we provided reconciliations between GAAP and non-GAAP measures in our press release and in the appendix of our presentation materials, which are available on our website. With that, I will turn the call over to Eric. Thanks, Jim. Good morning, everyone, and thank you for joining us today. I'm on slide three. The IDEXX teams across all three segments delivered better than expected results in Q2, despite continued macro uncertainty. I'd like to thank our teams around the world for their hard work and strong execution as they navigated a very fluid environment. Our teams are bound together with a simple value creation equation that adapts quickly to address challenges and deliver on opportunities. We deliver differentiated critical impact from low points in our customer's bill of materials, typically at the component level, allowing us to quickly shift towards advantage applications, and increasingly so with integrated growth opportunities, most often driven by changes in customer demands. I'd like to walk through a real-time growth example of this dynamic tuning at Airtek, a business acquired in 2021 with NHST, to illustrate our team's agility in action. Airtek delivers customer value through pneumatic solutions, most often in the form of specialty blowers or valves. It sits next to our outstanding gas business with some light integration within channels to market and functional leadership. Four years ago, at the time of acquisition, their product lines were growing within mutually exclusive application sets supported by good operational performance with room for targeted improvements. Today, they are growing much faster as they've helped their customers shift their core businesses towards solutions within data center applications, specifically fuel cell power support and thermal management via liquid cooling. AirTag's two product lines benefit from joint exposure to this fast-growing space, and the leadership team at GAST is leaning in to help them drive process efficiency to fully leverage profitability to support group performance. Finally, applying 80-20 has helped them focus and fully resource these applications in a powerful way, which in turn is multiplying their impact. As data center solutions scale, our customers have experienced additional pain points outside the scope of pneumatics. This is where other IDEX capabilities come in, and in this case, Airtek is looking to Mott to address a key technical problem to drive significant system efficiencies. Their solution is currently under review by a key customer. Finally, they are also exploring operational opportunities that leverage IDEX's infrastructure and world-class capabilities in India. This is a great story that advanced in the second quarter. It demonstrates the power of our dynamic business model, our commitment to 80-20, and the leverage of IDEX's global capabilities with proprietary capital deployment via M&A as the key catalyst. We're confident in the pneumatics team's plans to drive even more growth and value creation in the quarters and years to come. Turning to an overview of business conditions, we saw some impactful patterns play out in Q2 and July that help us think about our likely path to close out the year. First, we have some areas of healthy demand, including food and pharma applications within IHNS and MPT, space and defense applications in MOT and optical technologies, North American fire, downstream energy custody transfer, intelligent water, and data center thermal management within pneumatics. Weaker areas include chemicals, auto, semiconductor lithography, and ag. The rest of the portfolio was pretty steady. Within Q2, there were some strong demand inputs in the form of trade policy positioning statements that were unpredictable, shocking the system and setting up sine waves of up and down order patterns. Daily demand levels moved dynamically between policy announcements and negotiation deadlines as customers attempted to de-risk tariff and pricing exposure. In the end, we see two implications. First, the patterns are moving around a relatively stable baseline that didn't line up well with the quarter endpoint. However, in July, we saw a modest order recovery build through the month. Second, and most important for us, The sudden and unpredictable shifts in policy are slowing down decision-making and conviction for larger orders. This has the highest go-forward impact for us in some more recently acquired areas of IDEX where strong growth funnels supported earlier expectations of accelerating back half revenue and margins. As a result, we are lowering our back half financial projections to better reflect this dynamic. We're very confident in the quality of our businesses. They are set up to solve some of the most complex challenges and advantage markets. Coupling this with our long-established operational capabilities, we believe we are very well positioned to drive attractive growth and value for all of our stakeholders. I'm now on slide four. Before Akhil covers the financial details of both our Q2 performance and our updated guidance, I'd like to step back and help you understand our journey and the progress we are making towards long-term revenue and margin acceleration through growth platforms. Our goal is simple. Extend IDEXX's growth potential through variable levels of integration to win in advantage markets where customers are demanding more solutions impact than any one single business unit can provide alone. Here are two examples. First is HST's IDEXX health and science platform that we built through thoughtful capital deployment over the last 20 years. Today, IHNS is an integrated global platform of world-class technologies that has added thin-film optics, system integration, and microfluidic capabilities to its core fluidics portfolio. We've divested some small non-core businesses along the way, consolidated like businesses together in a state-of-the-art greenfield site in Rochester, New York, and integrated commercial and technical teams across the platform. This work has driven strong value for customers and shareholders over the years and is well-positioned to meaningfully do so in the years to come. An example of this work in action today involves a key win for integrated sample prep within a cutting-edge protein analysis instrument. Our team designed a metal-free ceramic valve for cutting-edge core performance. Then, a cross-business development team enhanced overall systems performance by incorporating a suite of our platform's fluidic connection technologies. They even pulled on nanofiltration technologies from Mott to take everything one step further. Finally, they collaborated with a customer to integrate all the technology deeply within the front end of their instrument. The initial response to the customer's product line has been outstanding. Our second example is the strong value created over time through the build out of optical technologies, a cornerstone within HST's materials science solutions platform. We built the Optical Technologies Group over the last 14 years, both organically and through multiple transactions, broadening its capabilities. We're taking another step forward today with our news of the acquisition of MicroLAM, a high-quality bolt-on that brings proprietary difficult-to-machine forming capabilities into our already-advantaged technical toolbox. Over the years, we helped drive a culture of 80-20 to each individual company entering IDECs. to drive focus around core capabilities while rapidly improving profitability. In later stages, we increasingly encourage joint commercial and technical collaboration between units to attack emerging applications within semiconductor lithography and metrology. Most recently, the group is accelerating its growth by working together to support advanced space and defense applications. MicroLAM is very complimentary here, given their customer access points and technical capabilities. Moving to slide five. Since 2020, we have focused a greater portion of capital deployment towards M&A to accelerate building and expanding our growth platforms. In the last three years, through several acquisitions, we created HST's material science solutions platform. And last year, we added Mott, which is highly complementary to many HST businesses, adding nanofiltration technologies at scale, a meaningful and very attractive capability for us. I'd like to dive a bit deeper into both of these areas to illustrate the strong links to our past success and frame the potential for even faster growth. I'll first discuss our value creation journey building MSS. We started with a highly optimized optical technologies business, which we just discussed. Next, we applied 80-20 and operational improvement tools to our acquisitions of STC and all businesses within the muon group. As a reminder, a large piece of our cost optimization work this year is substantially complete within these areas. Today, our teams are focusing resources on the best customers and solutions as we align teams commercially and technically to win in advanced markets. While our growth and margin expansion acceleration has hit a near-term air pocket as our strong positioning with advanced semiconductor lithography has caught up in geopolitical tensions, we continue to be excited about our funnel of growth opportunities overall, and in particular, attractive markets like data center optical switching. Here, the Muon team recently secured a multi-year win through collaboration between two of its units, a great example of our integrated growth strategy at work. And teams are attacking other attractive opportunities within a variety of advanced semiconductor applications, space and defense, sustainable energy, and precision forming. The businesses within the MSS group are truly outstanding. They are highly differentiated and complement each other well as they provide trusted solutions to advantage markets. Turning to Mott, we are aggressively deploying 80-20 as we help the business grow and optimize profitability. Mott has an outstanding track record of deploying its core specialty filtration capabilities in a variety of end markets to build important scale advantages. The solutions have ranged from differentiated components, like high purity gas filtration elements that serve as critical consumables within semiconductor lithography, to large-scale filtration solutions that embed MOTS core technology within engineered SCID-based solutions. Both lines of businesses are strong within their own relative merits, but our collective teams are leveraging 80-20 and product line strategy to tune towards more IDEX-like highest differentiation, highest margin, component-level solutions. This should even out the growth path over time and best fuel MOTS development resources towards growth with the highest return profiles. Mott's acceleration has slowed a bit this year as the larger, more complex opportunities within their funnel were impacted by the policy-driven demand uncertainties described earlier. We expect Mott's growth will continue to accelerate this year, but we've recalibrated its growth potential for the back half of the year given the pause we are seeing in customer decision-making. As the team works through these headwinds, they are attacking a rapidly growing set of opportunities within space and defense and high-purity semiconductor applications that match all screening elements for the best IDEX-like businesses. The core differentiation of Mott's nanofiltration technology deployed at scale is powerful. We continue to love the business and the team and confirm that the acquisition will be accretive exiting the year. Putting our past and present together, you can see that we're following a simple and powerful growth formula that's long-driven value for IDEX. But we're more intentional today as we deploy capital and integrate more rapidly to support the emerging needs of today's fastest-growing markets. And while we didn't dive into them today, I'd like to mention that our intelligent water and fire and safety platforms are very well positioned in this regard with very similar stories of focused cross-business collaboration. I'll pass it over to Akhil to discuss our financials and our updated outlook in greater detail. Thanks, Eric, and good morning, everyone. Let's turn to slide six. As Eric mentioned, in the second quarter of 2025, IDEX delivered strong financial performance. While revenue came in toward the midpoint of our guidance, we outperformed on both adjusted EBITDA margin and adjusted EPS. All the comparisons I will discuss will be against the prior year period unless stated otherwise. In the second quarter of 2025, orders grew organically by 2%. We saw positive demand in a pharmaceutical, energy, and agriculture end markets, along with continued stability in diversified industrial and water. However, softness persisted in our automotive, rescue tool, and parts of our semiconductor businesses. Organic sales in the second quarter increased 1% year over year. We benefited from positive price across all three of our segments, as well as favorable results in businesses serving aerospace, defense, data centers, pharmaceuticals, and North American fire OEMs. Strength in these areas isn't fully visible given challenging prior year comparisons within our FMT and FSD businesses, as well as continued weakness within semiconductor and automotive. Adjusted gross margin declined 10 basis points year-over-year, primarily due to the near-term dilution from the mod acquisition, unfavorable mix, and volume deleverage. These effects were partially offset by favorable price cost and operational productivity net of employee-related costs. Adjusted EBITDA margin declined 40 basis points to 27.4%, reflecting our gross margin performance and lower variable compensation expense in the second quarter last year. Our platform optimization and deal-layering initiatives and cost containment efforts delivered a combined $14 million in savings during the quarter, in line with our plans. Both of these remain on track to achieve $62 million, or $0.63 per share, in full-year savings. Additionally, we continue to work our baseline productivity improvements plan for this year, some of which are going to be influenced by volume. Free cash flow of $147 million increased 25% year-over-year and represents 94% conversion versus adjusted net income. The increase was driven by higher earnings and favorable timing of receivables, partially offset by payments related to our platform optimization and deal-airing actions. We ended the quarter with strong liquidity of approximately $1.1 billion, including $568 million in cash and $541 million in undrawn revolver capacity after paying down $100 million in long-term debt and $12.5 million in short-term borrowings during the quarter. Finally, we deployed another $50 million to repurchase IDEC shares in the second quarter, taking our total through the first half of the year to $100 million. Now quickly, some color on our results by segment. I'm on slide seven. In HST, second quarter organic orders increased 2% and organic sales increased 4%. Revenue growth was supported by positive price as well as volume increases within our pharmaceutical, space, defense, and data center-focused businesses. Demand for advanced semiconductor lithography solutions and automotive continued to face headwinds. Adjusted EBITDA margin of 26% increased sequentially by 40 basis points, but tracked lower than we anticipated given mixed pressure within our material science solutions and MOP businesses. Turning to slide 8, in FMT, organic orders increased 7% and organic sales declined 2%. From an orders perspective, we experienced growth in our downstream energy, agriculture, and municipal water businesses. As we said earlier, our industrial distribution businesses posted daily order rates in line with our expectations through May, but pulled back in June, weighing on our expectations near term. On the revenue side, our chemical, energy, and agriculture businesses declined against challenging prior year comparables. Semiconductor remains challenging, and water was down year over year, which we attribute mostly to timing. Positive price was a partial offset. Adjusted EBITDA margin of 35% increased 130 basis points year over year as positive price, cost, and productivity improvements more than offset volume deleverage. I'm on slide nine. FST organic sales grew 2%, but organic orders declined 7%. Our fire and safety business continues to benefit from strong OEM demand and strong adoption of our integrated solutions. But order patterns are somewhat choppy near term, which we attribute mostly to timing in both our fire and safety as well as dispensing businesses. Adjusted EBITDA margin of 29.4% increased 40 basis points year-over-year given positive price cost, which more than offset net productivity, volume deleverage, and mixed headwinds year-over-year. Now, please turn to slide 10 for our updated full year and third quarter guidance. We are adjusting our organic sales growth guidance for the full year to approximately 1% versus 1 to 3% previously, given the up and down day rates. Slower customer decision making on larger orders and a key semiconductor customer lowering their growth expectations. Adjusted EPS guidance moves to 785 to 795 versus prior guidance of 810 to 845 for the year. We are adjusting our profitability outlook for the second half of 2025, given the flow through impact from lower volumes and expectations for continued mix headwinds near term. In the third quarter, we expect 2 to 3% organic revenue growth and adjusted EPS of $1.90 to $1.95. Our third quarter revenue guidance reflects our recent order performance and current backlog. We expect that revenue will be relatively flat in the third quarter versus the second quarter across each of our segments. Our adjusted EBITDA margins and adjusted EPS are expected to decrease sequentially driven by anticipated timing of corporate costs and slightly lower volumes in related deleverage. From a tariff standpoint, we have updated our 2025 tariff impact to be approximately $50 million, with about two-thirds of it recognized in 2025. We expect to fully mitigate tariff-related inflation with price increases and additional sourcing and supply chain savings we are actively pursuing. Our 2025 guidance does not include the possibility of additional tariffs. We expect to take mitigating actions as needed to offset these additional tariffs if or as they occur. Now, please turn to slide 11 for our capital allocation strategy. We maintain a purposeful and return-focused approach to capital allocation supported by a strong balance sheet, robust cash flow generation, and meaningful borrowing capacity. Organic investments remain our highest priority as we look to consistently drive innovation across our platforms. From an inorganic standpoint, our current focus is on opportunistic tuck-in M&A to scale and expand critical capabilities in advantaged markets. We continue to work an active funnel to broaden our capabilities and will continue to seek opportunities to leverage 80-20 and operational improvements, which together enhance the IDEX advantage moving forward. In addition, we are focused on returning capital to maximize shareholder value. We have a long track record of growing our dividend as we grow earnings. We also consistently evaluate additional return of capital to share repurchases. June, year to date, we have paid $106 million in dividends and repurchased $100 million of common stock, including $50 million in the past quarter. And we have $440 million remaining in our current authorization. As we focus on leveraging the larger platform building investments made over the past few years, we expect a more balanced approach to capital deployment in the near to immediate term. With that, I will now turn it back over to Eric. Thanks, Akhil. I'm on slide 12, where we highlight the key value drivers for IDEX shareholders. While we have recalibrated our financial expectations for the second half of 2025, primarily due to the pause in customer decision making, We are paving the way for sustainable value creation with all three pillars here, contributing and thoughtful capital allocation to drive attractive shareholder value and return sustainably going forward. Thank you, and with that, I'll turn it over to the operator to take your questions. Thank you. We will now be conducting a question and answer session. If you would like to ask a question, please press star 1 on your telephone keypad. A confirmation tone will indicate your line is in the question queue. You may press star 2 to remove yourself from the queue. For participants using speaker equipment, it may be necessary to pick up the handset before pressing the star keys. One moment, please, while we poll for questions. Our first question comes from the line of Nathan Jones with Stifel. Please proceed with your question. Good morning, everyone. Good morning. I guess I'll start with the delayed orders on the semi side. Obviously, there was plenty of disruption going on in the second quarter. We are starting to get a bit more clarity on trade and tariffs. Maybe you can just talk about that as a catalyst for getting some more decision-making going on that front. We have been waiting for these orders to improve in the back half. What is your level of confidence that these things will actually come through in the next couple quarters? I mean, projects can be deferred indefinitely. So maybe just talk about your confidence on those projects coming through versus continuing to be deferred. Sure, Nathan. You started off talking about semi, but then I think the question was more broadly framed around large orders in general. So I'll kind of hit it that way and probably go in reverse. And so, look, no doubt, as we talked about in the prepared remarks, we saw some oscillation in both small order patterns and decision makings around those announcements and negotiation deadlines. What was interesting here, and I think probably gives us the most confidence, is, as you know, some of that just timed out where in early July, you know, we got some resolution here that things were moving forward. And I think everybody got a sense of where the pattern is likely to settle in. And so we saw order recovery throughout July in both buckets, frankly, on the small order side and on the decision-making piece of larger orders. And so I think part of the confidence comes from our sense that while there's still announcements and things to come, there's kind of a predictable nature of where they're likely to settle in, how they're likely to play out. And we're hearing that reflected in the conversations that we're having with customers and decision-makers along the way. So I think the confidence primarily comes from a pattern that partially is in the current quarter that's played out here in July. Again, one of the reasons we dove as far as we did into the new acquired larger businesses within HST is that's really where most of the impact comes here in terms of the shift in guidance. We had both those businesses, especially on the mod side, had a really, really strong funnel. They typically kind of run that business in a nonlinear way that kind of races to year end. And really, as Q2 played out, they just saw a lot of kind of frozen decision-making there. Much of it released here in July. And so then ultimately you have kind of a physics question in terms of how much they can produce in Q4. But even some of those orders coming in for that business and others along the way, we saw the same thing in water with recovery in July, I think gives us a better feel as we enter the back half of the year that things are stable. They're still likely to change up and down, but that baseline is pretty stable in both sides of the business. You opened the question around semi in general. I just want to say, you know, we see semi exposure in different ways in different businesses. Probably the piece that has given us the most pressure when we talk about mix and talk about semi-mix in HST, it's really a large chunk of business in the muon business up in our MSS platform. It's outstanding, cutting-edge lithography componentry that we make there. That's coming from a customer that initially had talked about inventory timing in the first half of the year and I think is more settled now that, hey, things are going to be kind of steady for a while, largely because of some of the geopolitical tensions, restrictions, and things that have also played out. Now, the other pieces of semi within IDEX, there's a lot of them that are growing, growing well, some of them quite markedly in areas like metrology. We see that in optics. So it's kind of a mixed bag there depending on how we play out. But the pressure point for us is a portion of really high-quality business that looks like it's going to be flatter for a while. I would assume that that kind of stuff that you're talking about, there is also very high margin and very high incremental margins. You have cut the guidance, full year margin guidance by 100 basis points, which kind of implies 200 basis points in the back half. Is that really... You know, outsized impacts from what are very high margin businesses that aren't quite getting the volume that you'd anticipated. And when that volume comes in, those orders come in, we should start to see that margin improvement come back up. That is definitely a piece of it, especially on the HST side. That's some of the best business that we have in the acquired group. You know, some of the opportunities I mentioned is a partial offset, the great work they're doing on things like data center switching. I mean, it's equally attractive and over time will also complement it. But there's no doubt a return to growth there will really, really help profitability in that particular platform in HST. I'd say the second half of it, though, is really the acceleration of Mott. You know, we're tuning that business a lot. We've taken some costs out there. and they were heading already for a lot of volume and still are in the back half of the year. That's where you get full leverage. And so I think those two things together, you know, tuning and revenue and acceleration at Mott, and then ultimately a release on the really good margin business towards more acceleration would be the two chief components here that we'd be looking for. Awesome. Thanks very much for taking my questions. Thanks, Nathan. Thank you. Our next question comes from the line of Vlad Bistricki with Citigroup. Please proceed with your question. Thanks for taking my questions this morning. Eric, first off, can you just give us a little more granularity or specificity on what's embedded now in the current guidance? a continuation of current trends? I know you talked about sort of more predictability around the policy front, but how are you thinking about potential for any incremental volatility or downshift in those day rate trends that you've seen bounce around over the past couple of months, it sounds like? Yeah, I think really, again, we're going to end up talking here a lot about HST because the FMT and FSDP segments, we've got those. We had them originally modeled to be pretty steady, and that's kind of where they're sitting now. And they're performing really, really well. So I think we were able to kind of deal with what we had in the second quarter and come out of it with the rates in July. You know, maybe a little pressure on the third quarter, we would have chosen to accelerate that a bit. Ultimately, the recovery will help us get where we need to, and then we kind of got those running out from here. And so in HST, you know, that's where we had some more aggressive acceleration hopes with, again, those two most recently acquired businesses. We've moderated those a bit, but they are still moving forward. A lot of it coming from a pretty strong fourth quarter for Mott. We mentioned that we're confirming that's going to be an accretive business at that point. I kind of take us back to the beginning of the year. You might remember we talked about a large project that we booked in Q1. A portion of that starts to come out of the business and hit the revenue line in Q4. Some of the orders, even the ones delayed, are now in hand and will also support that, and it's kind of been the natural tendency of that business to run there. So we've We have some acceleration there, but we've tempered that acceleration a bit, and then it's generally steady in the other two segments. Okay, that makes sense, and that's quite helpful. And then just to follow up for me, within FMP specifically, I think you called out positive orders growth in the quarter, but There's also still a red line next to ag on the slide. So, Ace, can you just clarify or talk about what you're seeing and expecting within that specific market vertical? Sure. Just reminding everybody that, you know, for us, we've got two businesses there, the largest of which, while it has an OEM component, it's the smaller piece of the business. A lot of it just depends. It's components that farmers retrofit as they go and as they're planting and harvesting. So it's a little less tied to the dynamics of heavy capex and OEMs, but it's all related, certainly. I would say, look, it's still a rough cycle for ag. However, it's kind of played out better than we originally had hoped. And I think a lot of that is coming from a bit more confidence. Growing season's been pretty good. And our team there has done a really good job on the commercial side of things in terms of channel management and things that they're doing, expansion in Europe. So Put It Down is still a business, you know, that's in the lower part of the cycle, but performing above kind of the lower expectations that we had coming into the year. Understood. That's helpful. I'll get back into you. Thanks. Thank you. Our next question comes from the line of Mike Halloran with Beard. Please proceed with your question. Good morning, everyone. Hi, Mike. Not to belabor here, I just want to, Eric, make sure I understand the moving pieces. So it's not so much that there's been a deterioration. It's just that the pace of growth that you're assuming as you move to the back half the year is slower than you originally would have thought. on top of some of those project pushouts where I don't think that your optimism over a medium term has really changed. It's just the timing or the duration of when those actually hit has shifted. Is that a fair characterization? Yeah, no, that's, that's dead on. And partially here, this is, you know, we, again, we're really close to customers. I mean, we, you know, of course have a bunch of businesses that are rapidly turning components. So any inflection we tend to feel, um, a lot more sensitively and quicker than others. And so we just went through a quarter where there was tremendous up and downs and some periods of frozen decision making and then release points. It played out in kind of an unusual way and then resolved itself largely in the month of July. So from an ongoing confidence standpoint, I actually feel better given that I think everybody can kind of see the patterns that are working here. It appears to be reasonable. We can kind of draw a straighter line than we could coming into the quarter. We hear that from customers, distributors, end users, all over the place. But, you know, for where we are, I mean, we're often coming into a quarter with X amount of the backlog secured, and then we're hunting for the rest. That decision-making has an impact, had an impact in the second quarter for us. And most specifically, again, I just point to, you know, we really had some strong funnels up in those recently acquired businesses, and those acceleration rates, you know, we're dealing with a pause there and a timeout, again, with some resolution in the same exact capacity in July. So confidence level pretty good, but, you know, it was a period of oscillation and kind of strange patterns for us that just we're going to experience maybe more than some other businesses. That makes sense. And then just on the capital deployment side, Maybe just some thoughts on the funnel of opportunity. I know the tenor or the tone has been a little bit more measured about the pace of M&A. Is that a reflection of where the balance sheet is, a reflection of the opportunity set as you sit in the market today, and just maybe a little bit broader thoughts on the opportunity set holistically? Yeah. Well, I mean, obviously we talked about bolt-ons, tuck-ins, and then, of course, we announced one. I think it's largely the output from what the funnel looks like, you know, because if you think about it, if you step back here, I mean, as we dove in and talked about the material science solutions platform, you know, we took essentially an optics platform that we built over the time horizon that I talked about in my remarks, 14 years, and then we built the second half, largely pretty aggressively here over the last couple of years with the acquisition of the Businesses that form that unit. Now that it exists, essentially the next move and the piece we've been getting ready for are those tuck-ins and technology fillers that really then bolt onto a really great framework. And so it was always kind of the plan is to get it to this level, complete it with the technologies that we have, and then put complementary businesses like microLAM right next to it. You know, Mott's a little different. It was an unusually scaled business. It presented technologies that we'd not had in the portfolio. You know, so one of the things we see there is just wide applicability to almost everything we have in HST. So we're actually not forcing that one at the moment. We're getting a read on where it's, you know, kind of fits the best, where it complements things the most. We're using it as sort of a, as I said in the comments, something in the toolbox for everybody. to exploit. But I think the nature of capital deployment is really reflective of just whether it's fire and rescue, water, IHNS, and now MSS, these incredible platforms that have multiple touch points that we're attempting to take advantage of. Thanks, Eric. Thanks, Mike. Thank you. Our next question comes from the line of Dean Dre with RBC Capital Markets. Please proceed with your question. Thank you. Good morning, everyone. Hi, Dean. Good morning. Hey. I appreciate all the color you're providing here, because it is kind of an unusual, choppy, mixed kind of signals. And you guys are really good, historically, at being able to identify them versus expectations. So in the spirit of that, can you give us any calibration on the day rates? You said May was as expected, June declined, July was it up or stabilized and any kind of sizing of that, just because it's really important this quarter to get a sense of like the amplitude, you know, how far was June down and how much has July come back and what the implications are. Yeah. I appreciate it, Dean. I mean, look, it, it played out with each, each month kind of had its own little story over the last four. I think in, you know, April we talked about it, you know, we, we, Probably like a lot of business experience, some pull ahead pre-tariffs after the initial announcement. In May, as expected, we saw some of that come back, and we were probably at about the position we thought we'd be at the end of May. We always knew June was going to be a pretty key month, particularly with some big announcements sitting right in the beginning of July, concurrent with a holiday. And so the backlog reductions that you see overall for IDEX, all of it came out of the month of June. really over kind of the last three weeks, I'd say, right into that U.S. holiday that we had at the beginning of July. Then we got the news. The news said, hey, things are delayed. You start to get more clarity on like how this is ultimately probably going to play out. And then all through July, you saw a steady build back. And I'd say as we closed July, in that four-month period, we ended up out exactly where we thought we would. It's just the patterns themselves were pretty dynamic. pretty different. And certainly, as we said, at least from a larger decision-making perspective, I think froze some people as they were really putting their concentration towards ups, downs, and things that they could do to try to mitigate potential tariff hits or things like that. That's ultimately what was playing out. Good. That's helpful. And look, we've all seen periods in the macro where customer decision-making slows down. You know, you need extra signatures. It's just longer to get to. Yes. But it really does sound like for your guidance cut, it's concentrated in Mott. So how much of the guidance cut is attributed specifically to Mott? Well, I'd say two places, really. And you've got to think of this from a revenue and then the profitability flow through along it. It's really from the MSS group, which I talked about right next to Mott. I think the issue there is not so much on the revenue line. It's the continued mix issue that we have with a great piece of semi-lithography business that's kind of flattened out for us, and we had long hoped that that was going to start to move again. But revenue largely solid and, in fact, growing around it, just not at the same kind of mix quality. And then from Mott's standpoint, as I said before, that really historically has been a nonlinear business that kind of starts low and builds. throughout the quarter. That was the plan of attack for it in 2025. Large funnel, I mean, they've got a funnel that's frankly overbuilt for what they ultimately still need in the back half of the year. But that decision, kind of the frozen decision-making loop in the second quarter really delays just kind of the physics and fundamentals of what can possibly be produced as we exit the year. And so you're seeing that because That's where a lot of the margin appreciation is happening simultaneous to the volume stacking on. I'd say those two pieces, relative to what our previous call were, is the significant piece of the delta. The only trailing component would be, again, I think generally had those small order patterns not played out the way I described, we might have had a little bit more cross IDEX momentum into Q3. We kind of had to build through July to kind of get back to the zero point, but I put that as a trailing third and certainly not a chapter we're worried about going forward. Okay, that's really helpful. And just last question for me is, you know, the past couple of years, most of the consternation was around life sciences and the kind of destocking extended demand fall off that we went through. And that doesn't seem to be the case here. Can you just refresh us? Where has the life sciences gone during this period when I guess most of the focus here has been on semi, but just an update there. Are you seeing any blanket order changes as well? Really, I'd say the life science story is playing out exactly like we thought it would be. You know, it's a slow recovery off the bottom. It's growing low single digits. You know, there are some Some areas that are weaker, but they're generally offset by things that are stronger. So for, you know, talk around NIH funding and academia, that's definitely under a bit of pressure, but it's a smaller piece of our business. Those applications that are targeted to pharma drug discovery are strong and generally offsetting them. And then that core kind of moderate recovery heading to something better in the future is playing out exactly as we thought it would be. That's great to hear. Thank you. Thanks, Dean. Thank you. Our next question comes from the line of Brian Blair with Oppenheimer and Company. Please proceed with your question. Thank you. Morning, guys. Hi. You mentioned that water was down in the quarter. Just a little bit of a surprise. I guess if I heard correctly, that was attributed to timing. Hoping you can offer a little more detail on water performance in Q2, and then more importantly, what your team's seeing on an underlying basis where there's opportunity versus perhaps risk in terms of platform demand and what level of growth do you expect in the back half? Yeah, I'm glad you asked. Actually, what I isolated there is that water, which has some larger order components in it, more than some of the rest of IDEX, had some of the same kind of frozen timing dynamics in Q2 that we talked about elsewhere. A lot of that released in July and really does nothing to impact, you know, what we've generally seen, which has been a favorable run out of that business. And we've actually got good numbers for it going forward. So really no pause in water. It's just, I was able to reference that that same dynamic played there and released nicely for us in July. Okay. Understood. And circling back to micro lab, that's an interesting tuck in the technology. I, I, admittedly not familiar with. Can you offer a little more color on the strategic fit and synergy with the MSS platform? And then as we think of, you know, think about your tuck-in strategy going forward, how does microLAM compare to the average prospect in your funnel, just, you know, deal size, revenue generation, et cetera? Hi, it's Akhil here. I'll take this one. And then Eric, please feel free to add in any color. So when you think about micro lamb, right, it sort of plays in the same workflows that our optical businesses do. When you think about what we do in optics today, right? A lot of that is on the coding side of the business, but micro lamb is essentially a provider of precision optics. So they actually manufacture the optic, which can then get coded. So there's a really nice complementarity here and a strategic fit between our optical technologies business and micro lamb. And so this is, as you know, MicroLAM. It's sort of, it will sit within our MSS platform. And when you think about some of the other capabilities we have in there, the touch points are really interesting and unique. And I think we can drive a lot of value there. As we mentioned, when we think about MicroLAM, right, and how does it compare to, you know, will Tuckins look similar going forward? We've got a pretty, I think, broad funnel across our, you know, platforms here that we're cultivating pretty actively. And we've got a great foundation in place with the platforms that we have built. And so we expect to strategically, you know, find opportunities that help fill a capability gap, help us scale, or, you know, take us, open up some new customer doors. So it'll continue to look like that. You know, they have to have, I think one of the filters that we're going to be applying here is that they have to have an existing or a touchpoint with an existing IDEX business. So what you're going to see us is focus acquisitions, tuck-in acquisitions, around businesses that we know that we can bolt on and tuck into a platform for sure. And, again, we'll be targeting strong returns there. And, as you see with MicroLamb, right, we're going to be accretive in the first full year of our ownership. Just a couple other comments here. You know, while the technology is really, really complementary, I would oversimplify and say they're really good at making the optics. We're really good at polishing, coating, and assembling them. That's kind of the high level where this fits. They also have outstanding customer touch points that are really complementary in the space and defense sphere based on the technologies they have. So, you know, we've been actually working with these guys for a while now. Our teams know them, know them really well. Everybody in optics knows each other. And so we're going to hit the ground running here. I appreciate all the color. Thanks again. Thank you. Thank you. Our next question comes from the line of Joe Giordano with TD Cowan. Please proceed with your question. Hey, guys. Good morning. Hi, Joe. Good morning. Hey, so, like, last quarter, I thought the messaging was more like we are confident in the margin path because of actions that we've already taken that we know we're going to read out and that the back half acceleration was, like, really not dependent any longer on, like, these larger semi-orders coming in. The commentary you're saying today about Muon, it seems consistent with what you said last quarter, but the outcome of it feels different now. So maybe if you can give us a little color on how that messaging is changing. Yeah, I think once again, kind of in the same way when Nathan had this in a question, the only piece of semi here that really is playing out is a decent chunk of really high margin business that's kind of up in the Muon business. And that has been a piece we've been talking about. We talked about originally there was an inventory correction. There was a lot of customer feedback pointing to acceleration after that point. Kind of saying at this point, okay, based on our interactions with them, we don't see that coming here. We're not going to get the lift from that component of it. The rest of semi-elsewhere is really not an issue that plays a lot in things that are different. So I think it's that piece of it, and it's the acceleration of Mott. Really, we were â€“ Again, we've kind of always had a path that was going to run pretty aggressively for them, and having a timeout on some of the order flow there, we've kind of got a physics problem at the end of the year. It's still going to be a really, really strong Q4 for them, very similar to what they had last year. The funnel is still really strong. It's overbuilt, frankly, for what we need, and we see good business growth past that point. But taking some time out here from frozen decision-making for that business in particular does impact us. And then follow up here. The tie-ins to some of these new acquisitions to like existing businesses, like it makes sense. I get it. But are we like, has there been a pivot more? Does that kind of pivot to bolting on within kind of the context of IDEX? Does it get us into a situation where like there could be a more of a cascading effect of like a market issue across the franchise than you've had before? previously at IDEX where I felt like there can always kind of be a problem somewhere, but these businesses are largely independent enough that there's enough other things that would probably offset. It feels like, like one kind of problem somewhere has like more of an impact across more businesses now because of how they're kind of being tied in. Is that, is that accurate? I don't, I don't think so. I mean, I think I get the spirit of the question, but if we really step back and let's take mod as an example, And I gave several examples in the comments where, you know, MOTS technology is linking with current IDEX solutions. They actually cover a pretty wide range of end markets, everything from, you know, data center switching to something over on the life science side. And so that in itself to me says very IDEX-like. You can take a core capability. You can actually tune it in several different areas. Now, to the extent a lot of the work is being done here most recently in HST is It does tend to be bracketed in faster growing emerging markets, you know, that was not going to have necessarily the range and the fragmentation of a lot of our industrial kind of core FMT assets. So there's a different look and feel here. But, you know, we're not kind of chasing one singularity over and over and over here. These are very appropriable technologies. They just happen to be a lot of them more recently here in the HST side of the house, which is a little narrower. then certainly almost everything is narrower than what we have over in very, very mature industrial businesses. And maybe if I can just add, when you think about microlam, right, essentially the applicability of that technology is very broad-based, right? Eric highlighted some of the fast-growing markets that they're levered to, but when you think about sort of the markets they can serve, it's actually pretty broad-based from a capability standpoint. Thanks, Desmond. Thank you. Thank you. Our next question comes from the line of Jeff Sprague with Vertical Research Partners. Please proceed with your question. Hey, thanks. Good morning, everyone. Hey, hi. I wonder if we could just get to kind of the internal cost and productivity actions. Comment was made in the pitch that they're on track, but some vulnerability to volume weakness, which I get, you know, makes sense, obviously. But can you just level set us on what you've accomplished year to date, what remains to be done in, you know, the back half of the year. And if there's any other interpretation we need to add to your comment about maybe, you know, volume risk to those aspirations. Hey, Jeff. It's Akhil. I'll take that one. So if you recall, we had three buckets of cost actions. The first was the platform optimization. and de-layering initiatives. And that was the 42 million that we had talked about. So that's in place. We're actually at run rate. And so year to date, we've, or I would say in the second quarter, we achieved 11 million of that. And year to date, it's about 20 million. And then when you think about the second bucket, right, that was the 20 million of cost containment. Again, we expect that to hit run rate in this quarter. And that's about 4 million. And then when you look at the total, right, between those two buckets, We have we're at about 23 million and will recognize the balance of those savings in the back half of the year and Really the third bucket is our baseline productivity. We're still pursuing that but some of that is a function of volume Which we will we expect to again ramp in the third and fourth quarter Got it. Thanks for that clarification And then also on the so-called OB3 or Big Beautiful Bill, whatever we want to call it here, are you expecting some cash flow benefits from the change in R&D deductibility or any other impact on your financial results in 2025? Yeah. And, you know, it's not only been the OBB, but you've also got some state tax laws and foreign tax laws that have actually changed this year. That's why when you look at the third quarter, right, you see your tax rate bumping up just marginally, that reflects really a true-up of the tax changes and rules that are going into effect for the year. And then, therefore, when you think about our tax rate overall for the year, you see it coming down, which would imply a lower fourth quarter. But the OVB does help us from a cash standpoint and cash taxes, and it is supportive of incremental cash there. Great. And then maybe just one little loose end also. Just on price, it sounded like it was â€“ mostly positive across the corporation. Can you just aggregate that for us? What was your price capture in Q2? Yeah, so when I think about price capture, right, for the second quarter, we were just shy of 3%, right? And let me just take you back, right? When we thought about price, we implemented that in the first quarter. and that's about a percent, and we came into the second quarter. Tariffs got announced, so we were responding to tariff environment, and that had us not only with traditional, but the tariff piece added on top of it that put us right under the 3% mark for the quarter. And I guess you'd expect something similar for the year, maybe a little bit of dial back, though, as the tariffs faded, right? That's right. We're actually expecting a slight acceleration because if you think about when we put our tariff pricing in effect, right, it went into effect in the Q2, so we didn't realize the full benefit in the quarter, and you'll do that going forward. Now, this obviously assumes the current rules that are in place. As August 1 comes to bear and then there's other deadlines or tariffs move around, we'll continue to respond accordingly. Great. Thanks for the feedback. Thank you. Our next question comes from the line of Rob Wertheimer with Muleus Research. Please proceed with your question. Thank you, and thank you for all the color around customers. It's been helpful. Just a quick follow-up on that. I mean, to the extent that you know when you talk to them, is the uncertainty largely tariff-related? There's obviously a few other areas of uncertainty in the world, but as we get stability on tariff, I mean, maybe that's what unlocked July a little bit. Is there more of that? And then just to tack on my second one, your M&A activity has been great. Is there any related M&A freeze in the market either for you or other potential buyers or sellers from the uncertainty we're seeing? Thank you. Yep. I would say probably 90% of all conversations are related to trade policy. And the things that we're covering here as we talk through Q2. And it really comes down to, you know, I think two things. Anybody who's working a larger order with us, it's generally, remember, we're a component level to something much bigger than we are, and so it becomes a stack-up issue, and I think singularly becomes how much is it going to cost, and I need to know that. Is it likely going to change again? To your point, there are other factors out there, but they really don't enter the conversation much, or they certainly didn't in the second quarter. It was kind of where's this going to go, where's it going to settle out, Is it going to happen 10 days from now, 20 days from now, 30? How can I sort of move my things around? Again, with somebody on our side, that's generally pretty rapid fulfillment. So there's not a lot of buffer in between us and that conversation, and that's largely what played out. So I do think certainty in that particular area is a really good thing for us and others. And when I say certainty, that's a relative term around a reasonable band kind of in a way to anticipate and call information. as we experience both sides of those conversations, potential things that could happen and what ultimately plays out. So I think that's really, really positive. And on the M&A front, look, I would say that, you know, early on in the quarter when all of these tariff announcements went into play, there was really a freeze in the market, and we saw a number of sale processes that were due to come to market get halted. And now I would say that's all thought out and activity is starting to pick up, and that's just really a general, I think, view of the market at the moment. Thank you. Thank you. Our next question comes from the line of Matt Somerville with DA Davidson. Please proceed with your question. Thanks. I just, again, want a little more clarity here. That $20 million in cost containment was a hedge against what exactly, if it wasn't a hedge against some of the things you're describing on the call as driving down your EPS guidance for the year? And then have a quick follow-up. Yeah. Hey, Matt, this is Akhil. So this was a hedge against downturn in volumes. Now it only captured a certain sort of downtrend in volume, and what we're calling here is slightly more than that. So you know, that containment action is in place. It is supportive of our back half, and again, it does ramp this quarter, and then it'll be fully at run rate in the fourth quarter. Okay, and then... Throughout your prepared remarks and a few times during the Q&A, Eric, you referenced, you know, your data center-related exposure. Can you maybe size that up for us in terms of roughly how much revenue that will generate for IDEX in 25? And, again, just kind of big picture, you know, where that can sort of go over the next two to three years for the company. Thank you. Yeah, look, it's not a giant part of IDEX. It's a decent part of the air tech business that I talked about. You really don't see it over in gas. So if you're looking at performance pneumatics, air tech's only a portion of that, and this is becoming a larger portion of their business. So that starts to dimensionalize it, too. It's important for that business, not yet rising to a major catalyst for IDEX. What's interesting, though, is then we're starting to see it in other places. I mentioned the wind and the Muon Group, again, these are very peripheral kind of applications. It's not that massive stuff that you see around the center of a data center, but it's interesting little niches off to the side. What it can become from here, great to see these initial wins because, as you know in this space, I mean, often you can take something that's working and delivers performance and efficiency in one area and run to lots of others and deliver that as well. So, I mean, our commercial teams are doing that. I think as it goes, we'll certainly probably work to dimensionalize this a little better, talk about the funnel, but these are some interesting initial wins that are pretty early for us that we're going to continue to drive forward. Got it. Thanks, sir. Thank you. Our next question comes from the line of Brett Lindsey with Mizuho Securities. Please proceed with your question. Hey, thanks for taking the questions. Just first one on China, pretty sluggish here in the quarter still based on results thus far. I know IDEX exposure isn't huge there, but you do have some larger landed exposure indirectly into China and HST. So just any color on what you're seeing in the region and then what are the expectations for the second half of the year there? Yeah, I mean, certainly we wouldn't say that it's different conditions there. I mean, we're seeing the same thing in terms of, you know, not really, really strong. It, again, is a small piece of what we do, about 6% overall of revenue. We kind of surgically attack that, a product line at the time. You know, probably the areas of pressure that we would note, you mentioned one of them, you know, for our HST customers, that's an area they've long been talking about, and our you know, concerned about in terms of rates and when it might recover and how stimulus programs may help that. We do a little bit of direct shipping there that has been softer. Some rescue, we've talked a little bit about the rescue business. We've got a decent franchise up there that's also been impacted by some of the slowdowns. The core that we have around it, I mean, they're generally really appropriate. They do incredible things for that local economy and they're you know, kind of branded at a level that's long been localized for the geography. So I would say it's pressured. It's small for IDEX. You know, we're treating it accordingly as we think of resourcing investments. In many ways, you know, kind of our Asia-Pac concentration is China and India, very surgical and specific. And the India side is more than offset that from just really strong fundamentals. Great, and then maybe shifting back over to tariffs, so you're moving from the $100 million to the $50 million. Could you just expand a bit on some of the underlying assumptions there? Are you assuming the incremental copper tariffs embedded in that assumption, and then any other color on some of the regional tariffs would be great? Yeah, so what's not embedded in here is obviously the copper, as you mentioned, and then the Finalized rules around what's going to happen with Europe, Japan, that's also not in here. I know there's been an announcement, right, but we're waiting for further clarification on how that's going to be implemented. And then you have Taiwan, China, any changes there versus the status quo is not in here. But generally, if there are incremental tariffs, right, we'll continue to offset that one for one with price. All right. Appreciate all the detail. Thanks. Thank you. Our next question comes from the line of Andrew Vescaglia with BNP Paribas. Please proceed with your question. Hi, good morning, everyone. Hello. I apologize if I missed this, but what were your expectations for MOTS growth into the year, and then where do you see that playing out for the full year? What will the growth be? Yeah, look, I would say from a MOTS standpoint, right, when we announced the transaction last year, our our expectations was the business were going to improve the margins in that business, and that was going to be over a longer period, and we expected the business to be able to deliver high single digits in terms of growth. I think where we are right now is more or less just given the pause where we're calling the business flat, and then it's just going to be a different trajectory. But again, our expectations for the business overall, as Eric mentioned earlier, right, we're excited about the business, the team itself remain intact, and we do expect to generate or our expectation is still to generate double-digit returns for the business over the longer horizon. Got it. And maybe, you know, a lot of like the detailed questions are taken. And so I like to take a, you know, ask a bigger, broader question, but, you know, we're seeing some trends across industrials where some peers are, you know, trying to reduce complexity in their businesses and, you know, making strategic decisions one way or the other to do that. How do you guys view your portfolio at this point, given, you know, the world has changed a lot in the last five years, even the last three, and you quite haven't been able to grow earnings. the way one would hope. So is there a conversation to be had or are you having those conversations where maybe you look to rather than acquire, divest anything or review your portfolio? Look, we always consider all the pieces of our portfolio along the year while we've talked a lot about the things we've added and we've added things more aggressively over the last four years. You know, we've pruned small to medium-sized assets along the way as well because, honestly, they're not going to scale. And to your point, they become more complex over time. In fact, they become relatively smaller as the business goes. And so I do think we consider both sides of the equation. I think really here, though, what you see is, you know, we haven't talked a lot about FMT. We haven't talked a lot about FSDP. I mean, to your point on complexity, I mean, we've taken a ton of complexity out of those two particular platforms, and they're performing really, really well. What we're doing within HST is, you know, we're arguably trying to move this portfolio over towards faster growing, more inherently advantaged markets, and doing it, the connection points between each business, in some ways, is taking complexity out of the equation as well, because it's taking a large suite of end markets and things where we could go attack them single units at a time to more concentrated energy towards a handful of really, really good markets where we're trying to set those initial specification points to generate the same kind of annuity streams that we had elsewhere in industrial businesses in the two segments that we're not spending as much time talking about. So we're kind of very active work on the HST side now. We're talking about it appropriately, but it's really to put it in a state where it's, frankly, inherently simpler than it is today. And then through all of it, looking at both sides of the equation, each unit has got to kind of earn its relative merits, and we talk about that constantly as we go. Yeah, okay. That's fair. Thanks, Eric. Thank you. And we have reached the end of the question and answer session. I would like to turn the floor back to Eric Ashleman for closing remarks. Okay, thank you. Thank you all for joining here. And, of course, today, you know, we talked about a lot of the work we're doing to put pieces of IDEX together to multiply our growth input. You've heard examples of that, you know, today reflecting on our past. We talked about IH&S and the optical technologies and the build-out of those, you know, over more than a decade or in some cases two. We discussed our present when we talked about AirTech and the many HST touchpoints that we have for MOTT. We didn't talk about them today, but, you know, the great work that's going on on the extended intelligent water platform, the automation growth that's happening in fire and safety, and then all of the future work, a lot of it within the MSS group and the larger MOT group work across HST. These are all examples of how, you know, whether it's a couple units or a platform coming together, They're able to go and solve problems in ways that are just very, very difficult for any one single unit, and we think are going to absolutely propel the company going forward. We thank you for your time today, your interest in IDEX, and we hope you all have a great day. Thank you, and this concludes today's conference. You may disconnect your line at this time. Thank you for your participation. Have a great day.